AAAAAA

   
Results: 1-25 | 26-50 | 51-58 |
Results: 51-58/58
Antigen-driven CD4+T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
Authors: Ferguson, NM deWolf, F Ghani, AC Fraser, C Donnelly, CA Reiss, P Lange, JMA Danner, SA Garnett, GP Goudsmit, J Anderson, RM
Citation: Nm. Ferguson et al., Antigen-driven CD4+T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy, P NAS US, 96(26), 1999, pp. 15167-15172
Reduced prevalence of the CCR5 Delta 32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex
Authors: van Rij, RP Portegies, P Hallaby, T Lange, JMA Visser, J Husman, AMD van't Wout, AB Schuitemaker, H
Citation: Rp. Van Rij et al., Reduced prevalence of the CCR5 Delta 32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex, J INFEC DIS, 180(3), 1999, pp. 854-857
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
Authors: Pontesilli, O Kerkhof-Garde, S Notermans, DW Foudraine, NA Roos, MTL Klein, MR Danner, SA Lange, JMA Miedema, F
Citation: O. Pontesilli et al., Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy, J INFEC DIS, 180(1), 1999, pp. 76-86
Outcome and predictors of failure of highly active antiretroviral therapy:One-year follow-up of a cohort of human immunodeficiency virus type 1 infected persons
Authors: Wit, FWNM van Leeuwen, R Weverling, GJ Jurriaans, S Nauta, K Steingrover, R Schuijtemaker, J Eyssen, X Fortuin, D Weeda, M de Wolf, F Reiss, P Danner, SA Lange, JMA
Citation: Fwnm. Wit et al., Outcome and predictors of failure of highly active antiretroviral therapy:One-year follow-up of a cohort of human immunodeficiency virus type 1 infected persons, J INFEC DIS, 179(4), 1999, pp. 790-798
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis
Authors: Koot, M van Leeuwen, R de Goede, REY Keet, IPM Danner, S Schattenkerk, JKME Reiss, P Tersmette, M Lange, JMA Schuitemaker, H
Citation: M. Koot et al., Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis, J INFEC DIS, 179(1), 1999, pp. 254-258
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma byion-pair high-performance liquid chromatography with ultraviolet detection
Authors: van Heeswijk, RPG Hoetelmans, RMW Harms, R Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH
Citation: Rpg. Van Heeswijk et al., Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma byion-pair high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 719(1-2), 1998, pp. 159-168
Strategies for rescue therapy
Authors: Lange, JMA
Citation: Jma. Lange, Strategies for rescue therapy, ANTIVIR TH, 3, 1998, pp. 75-77
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma
Authors: Renwick, N Halaby, T Weverling, GJ Dukers, NHTM Simpson, GR Coutinho, RA Lange, JMA Schulz, TF Goudsmit, J
Citation: N. Renwick et al., Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma, AIDS, 12(18), 1998, pp. 2481-2488
Risultati: 1-25 | 26-50 | 51-58 |